Aller au contenu

World Cancer Day

At the Université de Sherbrooke Cancer Research Institute (IRCUS), we innovate.

For World Cancer Day (February 4, 2026), IRCUS marks its 5th anniversary by unveiling 5 major discoveries from its laboratories and significant international collaborations.

Your support is essential to advancing the fight against cancer, one research project at a time.

Our High‑Impact Research 2026

[Translate to English:] Hugues Allard-Chamard

When the immune system goes off track because of treatment

[Translate to English:] Sheela Ramanathan et Subburaj Ilangumaran

The immunotherapy that no longer wants to play hide-and-seek with cancer

[Translate to English:] David Mathieu

Destroying metastases without damaging the brain through targeted radiosurgery

[Translate to English:] Mélanie Morin

Gynecologic cancer: an innovative treatment, yet not easily accessible

[Translate to English:] Richard Leduc et Pierre-Luc Boudreault

Medicinal chemistry tackles an “orphan” therapeutic target to treat aggressive cancers

[Translate to English:] Brigitte Guérin

By outsmarting time, a team improves access to an innovative treatment against metastatic prostate cancer

About the Université de Sherbrooke Cancer Research Institute (IRCUS)

The mission of IRCUS, its raison d’être, is to develop synergistic and innovative interdisciplinary research aimed at reducing the impact of cancer on people affected by the disease. In particular, the research projects conducted at IRCUS help advance the understanding, detection and treatment of all cancers, while also improving care and services.

In addition to conducting high‑quality research, IRCUS trains the next generation of students and professionals who are essential to tomorrow’s fight against cancer. It distinguishes itself through its transformative impact across all key stages of the oncology care and services continuum, encompassing prevention, screening, diagnosis, treatment, end-of-life care and life after cancer. This integrated approach enables the Institute to make a meaningful contribution at every stage of cancer patients’ journey.

By investing in world‑class research, IRCUS aims not only to reduce the impact of cancer, but also to transform patients’ experience at every stage of their journey.